Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer.
Sternberg CN, Whelan P, Hetherington J, Paluchowska B, Slee PH, Vekemans K, Van Erps P, Theodore C, Koriakine O, Oliver T, Lebwohl D, Debois M, Zurlo A, Collette L; Genitourinary Tract Group of the EORTC.
Sternberg CN, et al. Among authors: whelan p.
Oncology. 2005;68(1):2-9. doi: 10.1159/000084201. Epub 2005 Feb 28.
Oncology. 2005.
PMID: 15741753
Clinical Trial.